Roles
Scientific Director, The Miami Project to Cure Paralysis
Senior Associate Dean for Team Science
Co-Director, Institute for Neural Engineering
Professor of Neurological Surgery
-
Biography
Dr. Dalton Dietrich is Scientific Director at The Miami Project to Cure Paralysis and the Kinetic Concepts Distinguished Chair in Neurosurgery at the University of Miami Miller School of Medicine. He received his Ph.D. in Anatomy from the Medical College of Virginia in 1979 and completed a postdoctoral fellowship in the Department of Pharmacology at Washington University, St. Louis, MO, 1981.
In 1981, Dr. Dietrich joined the Department of Neurology at the University of Miami, with a joint appointment in Cell Biology and Anatomy, and in 1993 attained the rank of Professor. Dr. Dietrich served as Vice-Chairman for Basic Science in the Department of Neurology from 1995 to 1997. In 1997he accepted the position of Scientific Director of The Miami Project to Cure Paralysis. Dr. Dietrich also serves as the Senior Associate Dean for Discovery Science at the University of Miami Miller School of Medicine and Co-Director of the Institute for Neural Engineering at the University of Miami. -
Education & Training
Education
Post Graduate Training
-
Honors & Awards
No result found
-
Teaching Interests
In the past, Dr. Dietrich has taught a variety of courses in the area of Anatomy and Neuroscience as well as Mechanisms of Disease. Currently, he has limited teaching responsibilities but focuses on mentoring the next generation of scientist and clinicians in the area of brain and spinal cord injury. Over the years, Dr. Dietrich has trained 150 graduate students as well as a large number of postdoctoral scholars. -
Research Interests
Neuroprotection and Improved Recovery of Function following Brain and Spinal Cord Injury.
Research in Dr. Dietrich’s laboratory is focused on clarifying the pathophysiology of brain and spinal cord injury with the ultimate goal of developing new therapies to protect and enhance recovery of function. Over the last 40 years, Dr. Dietrich and colleagues have studied the cellular and molecular injury mechanism underlying various neurological disorders including stroke, cardiac arrest, traumatic brain and spinal cord injury. In terms of neuroprotection, he and his colleagues provided the initial preclinical data indicating that small differences in the temperature of the brain and spinal cord critically determine whether neurons die or not following neurological injury. These preclinical studies of therapeutic hypothermia have been successfully translated to the clinical arena, where patients are being cooled following out-of-hospital cardiac arrest, strokes, traumatic brain injury and spinal cord injury. Most recently, Dr. Dietrich and colleagues have investigated the importance of abnormal inflammasome activation in the brain and spinal cord after injury. These studies have uncovered a new therapeutic target for modifying the immediate immune response to injury. In addition to these studies, Dr. Dietrich and colleagues are using novel cellular and drug treatments to promote reparative processes and functional recovery after brain and SCI. He is the Sponsor of a first-in-man FDA approved clinical trial testing the safety of human Schwann cell transplants in people with severe SCI and a peripheral nerve bridging strategy for severe leg trauma. Most recently, Dr. Dietrich and colleagues are investigating the use of human adult cells derived exosomes as a novel strategy to protect and repair the nervous system after injury.
Dr. Dietrich has published over 425 refereed journal articles, 77 book chapters and 4 books. His published work has been cited over52,000 times and has an h-index of 1114 (Google Scholar). He has been listed by the Institute of Scientific Information as a “Highly Cited Researcher”, placing him in the top 0.5% of all scientists based on the impact his research has made on other scientists. Dr. Dietrich has been a thesis/dissertation advisor to 15 graduate students and has trained over 50 postdoctoral fellows and visiting scholars from all over the world. His research programs are supported by the NIH, Department of Defense, Veteran’s Administration, State of Florida and The Miami Project to Cure Paralysis. In 2023, Dr. Dietrich received the Javits Neuroscience Award for demonstrating scientific excellence and productivity in neurological research. He serves on many study sections for NIH, Department of Defense, Veteran’s Administration, and several Editorial Boards. He is currently Editor-in-Chief of the Journal Therapeutic Hypothermia & Temperature Management and Deputy Editor of the Journal of Neurotrauma. Dr. Dietrich is a founding member of InflamaCore, LLC and serves on The Scientific Advisory Committee for ZyVersa Therapeutics, Inc. -
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.